CMND News and Press, Caleminder Inc From 05/31/24

2024-05-31 10:43:44 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Mind Medicine...

The global market of no- and low-alcohol beverages estimated at over $13 billion in 2023 Vancouver, Canada, May 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on disc...

Clearmind Medicine Inc. (CMND) is expected to report for Q1 2024

2024-05-08 08:36:23 ET More on pre-market losers & stocks. Siyata Mobile Inc. (SYTA) Q4 2023 Earnings Call Transcript Integral Ad Science Holding Corp. (IAS) Q4 2023 Earnings Call Transcript IPO Roundup: Rubrik, Marex Group, Loar Holdings, and more Integr...

2024-05-07 11:56:30 ET DENVER, Colo., May 07, 2024 ( 247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB ), Hims & Hers Health, Inc. (NYSE: HIMS ), Nuwellis (Nasdaq: NUWE ), Clearmind Medicine Inc. (Nasdaq: CMND ), and reAlpha Tech (Na...

2024-05-07 10:01:47 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...

2024-05-07 08:37:20 ET More on premarket gainers & stock Bioventus Inc. 2023 Q4 - Results - Earnings Call Presentation Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript SciSparc to acquire vehicle importer AutoMax SciSparc gains on grant of patent for...

2024-05-07 08:31:48 ET More on Clearmind Medicine Inc. Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation SciSparc gains as Clearmind partnership yields 3 new international patent applications Financial information for Clearmind Medici...

Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated ...